Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells
- PMID: 22354972
- PMCID: PMC3320925
- DOI: 10.1074/jbc.M111.325027
Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells
Abstract
MicroRNAs regulate gene expression by repressing translation or directing sequence-specific degradation of their complementary mRNA. We recently reported that miR-203 is down-regulated, and its exogenous expression inhibits cell growth in canine oral malignant melanoma tissue specimens as well as in canine and human malignant melanoma cells. A microRNA target database predicted E2F3 and ZBP-89 as putative targets of microRNA-203 (miR-203). The expression levels of E2F3a, E2F3b, and ZBP-89 were markedly up-regulated in human malignant melanoma Mewo cells compared with those in human epidermal melanocytes. miR-203 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequence of either E2F3 or ZBP-89 complementary to miR-203. The ectopic expression of miR-203 in melanoma cells reduced the levels of E2F3a, E2F3b, and ZBP-89 protein expression. At the same time, miR-203 induced cell cycle arrest and senescence phenotypes, such as elevated expression of hypophosphorylated retinoblastoma and other markers for senescence. Silencing of E2F3, but not of ZBP-89, inhibited cell growth and induced cell cycle arrest and senescence. These results demonstrate a novel role for miR-203 as a tumor suppressor acting by inducing senescence in melanoma cells.
Figures
References
-
- Miller A. J., Mihm M. C., Jr. (2006) Melanoma. N. Engl. J. Med. 355, 51–65 - PubMed
-
- Pacheco I., Buzea C., Tron V. (2011) Towards new therapeutic approaches for malignant melanoma. Expert Rev. Mol. Med. 13, e33. - PubMed
-
- Russo A. E., Torrisi E., Bevelacqua Y., Perrotta R., Libra M., McCubrey J. A., Spandidos D. A., Stivala F., Malaponte G. (2009) Melanoma. Molecular pathogenesis and emerging target therapies (Review). Int. J. Oncol. 34, 1481–1489 - PubMed
-
- Eggermont A. M., Robert C. (2011) New drugs in melanoma: it's a whole new world. Eur. J. Cancer 104, 397–404 - PubMed
-
- Sun B. S., Dong Q. Z., Ye Q. H., Sun H. J., Jia H. L., Zhu X. Q., Liu D. Y., Chen J., Xue Q., Zhou H. J., Ren N., Qin L. X. (2008) Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology. 48, 1834–1842 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
